NCT03491410 2018-04-09
Breast Cancer Active Surveillance, Alternative Option, Aspirin Included
Centro Hospitalar Lisboa Ocidental
Phase 2/3 Unknown
Clinical Trials
4 trialsNCT01782274 2017-10-12
Proteome-based Immunotherapy of Brain Metastases From Breast Cancer
NeuroVita Clinic
Phase 2/3 Unknown
NCT00684216 2017-09-14
Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer
The Netherlands Cancer Institute
Phase 2/3 Terminated
NCT01572727 2017-03-09
BELLE-4
Novartis
Phase 2/3 Completed